MarketInOut Stock Screener Log In | Sign Up

Braveheart Bio Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Braveheart Bio Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,936.74 mln
Float21.11 mln
Earnings Date11/12/2026

Relative Strength

95 / 100
Top performer

Debt / Equity

0.01
Debt-free

ROE

-30.95
Deeply negative

ROA

-28.03
Deeply negative

Business Description

Braveheart Bio Inc. is a San Francisco-based company founded in 2024 that works to create new treatments for people living with heart conditions. Its main focus is on a pill-form medicine designed to address two forms of a heart muscle disorder that can make it harder for the heart to pump blood properly. The company is currently in the clinical testing phase of development.

Key Fundamentals

EPS-6.08
ROE-30.95
ROIC-841
ROA-28.03
EBITDA, mln-29.26
EV / EBITDA-70.26
EV / EBIT-70.24

Quote Details

Last 21.51
Change 0.32 (1.51%)
Open 21.29
Volume 533,666
Turnover 11,479,156
Average Volume 327,192

Financial Ratios

Current Ratio13.63
Debt / Equity0.01

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.33% 61 / 100   
1 Month 0.47% 66 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog